Literature DB >> 11576844

Familial testicular cancer and second primary cancers in testicular cancer patients by histological type.

C Dong1, I Lönnstedt, K Hemminki.   

Abstract

The Swedish Family-Cancer Database was used to assess familial cancer risks in first-degree relatives and the risks of second primary cancers in testicular cancer patients by the histological type of their testicular cancers. Standardised incidence ratios (SIRs) were employed to estimate cancer risks. Among 4650 patients, 1.3% were familial testicular cancer. Seminomas showed a 10 years later median age of onset than teratomas (30 versus 40 years). The familial risks of testicular cancer were 3.8 for fathers, 8.3 for brothers and 3.9 for sons; they were similar for the two histologies. The fraternal risks were elevated 2- to 2.8-fold for pure histologies compared with the mixed histologies. Significantly increased risks for subsequent cancers were observed in the stomach, pancreas, testis, kidney, bladder, thyroid and connective and lymphatic tissues in the patients. Our data support the contention that genetic predisposition is one of the major contributors to familial and multiple testicular cancers.

Entities:  

Mesh:

Year:  2001        PMID: 11576844     DOI: 10.1016/s0959-8049(01)00172-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Increased predisposition to cancer in brothers and offspring of testicular tumor patients.

Authors:  Sarolta Gundy; Mária Babosa; Márta Baki; István Bodrogi
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

3.  Cancer in first-degree relatives and risk of testicular cancer in Denmark.

Authors:  Rikke Baastrup Nordsborg; Jaymie R Meliker; Jan Wohlfahrt; Mads Melbye; Ole Raaschou-Nielsen
Journal:  Int J Cancer       Date:  2011-03-04       Impact factor: 7.396

4.  Risk of cancer in first- and second-degree relatives of testicular germ cell tumor cases and controls.

Authors:  Victoria M Chia; Yan Li; Lynn R Goldin; Barry I Graubard; Mark H Greene; Larissa Korde; Mark V Rubertone; Ralph L Erickson; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

5.  Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.

Authors:  Anand Pathak; Charleen D Adams; Jennifer T Loud; Kathryn Nichols; Douglas R Stewart; Mark H Greene
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-11       Impact factor: 4.254

6.  Familial risk of urological cancers: data for clinical counseling.

Authors:  Kari Hemminki; Xinjun Li; Kamila Czene
Journal:  World J Urol       Date:  2003-11-13       Impact factor: 4.226

7.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

8.  Younger age-at-diagnosis for familial malignant testicular germ cell tumor.

Authors:  Phuong L Mai; Bingshu E Chen; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Istvan Bodrogi; Lajos Geczi; Edith Olah; Ketil Heimdal; Sophie D Fosså; Katherine L Nathanson; Larissa Korde; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

9.  Familial risk in testicular cancer as a clue to a heritable and environmental aetiology.

Authors:  K Hemminki; X Li
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

10.  The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred.

Authors:  Phuong L Mai; Michael Friedlander; Kathy Tucker; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Radka Lohynska; Gedske Daugaard; Stéphane Richard; Catherine Bonaïti-Pellié; Axel Heidenreich; Peter Albers; Istvan Bodrogi; Lajos Geczi; Edith Olah; Peter A Daly; Parry Guilford; Sophie D Fosså; Ketil Heimdal; Ludmila Liubchenko; Sergei A Tjulandin; Hans Stoll; Walter Weber; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; Lawrence Einhorn; Larissa Korde; Katherine L Nathanson; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Journal:  Urol Oncol       Date:  2009-01-22       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.